A Menlo Park, CA-based venture aiming to reinvent temporary pacing, BioTrace Medical Inc. has successfully closed an $8.5M Series A funding round.
The company is singularly focused on developing medical solutions that promise to both improve patient outcomes and significantly reduce hospital costs. This fresh capital infusion is set to bolster BioTrace Medical's ongoing efforts to advance its specialized technology and further its mission within the critical healthcare landscape.




.png&w=3840&q=75)









